{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:03:19Z","timestamp":1789426999087,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,14]]},"DOI":"10.7759\/cureus.116241","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:14:56Z","timestamp":1789424096000},"source":"Crossref","is-referenced-by-count":0,"title":["Associations Between Selected Autoimmune and Immune-Mediated Conditions and Lymphoma Among Hospitalized Adults: A National Inpatient Sample Analysis"],"prefix":"10.7759","author":[{"given":"ChiAyrsh","family":"Ford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrazig","family":"Suliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine K","family":"Barrerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadin","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund E","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J, et al.. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006, 54:692-701. 10.1002\/art.21675","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-008-9151-8","article-title":"Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California","volume":"19","author":"Parikh-Patel A","year":"2008","unstructured":"Parikh-Patel A, White RH, Allen M, Cress R. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control. 2008, 19:887-94. 10.1007\/s10552-008-9151-8","journal-title":"Cancer Causes Control"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103084","article-title":"Primary Sj\u00f6gren's syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis","volume":"21","author":"Zhong H","year":"2022","unstructured":"Zhong H, Liu S, Wang Y, Xu D, Li M, Zhao Y, Zeng X. Primary Sj\u00f6gren's syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis. Autoimmun Rev. 2022, 21:103084. 10.1016\/j.autrev.2022.103084","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstr\u00f6m Smedby K","year":"2008","unstructured":"Ekstr\u00f6m Smedby K, Vajdic CM, Falster M, et al.. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008, 111:4029-38. 10.1182\/blood-2007-10-119974","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24141","article-title":"Autoimmunity and lymphomagenesis","volume":"124","author":"Goldin LR","year":"2009","unstructured":"Goldin LR, Landgren O. Autoimmunity and lymphomagenesis. Int J Cancer. 2009, 124:1497-502. 10.1002\/ijc.24141","journal-title":"Int J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.06.005","article-title":"Autoimmune diseases and hematological malignancies: exploring the underlying mechanisms from epidemiological evidence","volume":"64","author":"Hemminki K","year":"2020","unstructured":"Hemminki K, Huang W, Sundquist J, Sundquist K, Ji J. Autoimmune diseases and hematological malignancies: exploring the underlying mechanisms from epidemiological evidence. Semin Cancer Biol. 2020, 64:114-21. 10.1016\/j.semcancer.2019.06.005","journal-title":"Semin Cancer Biol"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","article-title":"Risk of malignancy among patients with rheumatic conditions","volume":"88","author":"Thomas E","year":"2000","unstructured":"Thomas E, Brewster DH, Black RJ, et al.. Risk of malignancy among patients with rheumatic conditions. International Journal of Cancer. 2000, 88:497-502.","journal-title":"International Journal of Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa330","article-title":"Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs - a Swedish cohort study of risks by time, drug and lymphoma subtype","volume":"60","author":"Hellgren K","year":"2021","unstructured":"Hellgren K, Di Giuseppe D, Smedby KE, Sundstr\u00f6m C, Askling J, Baecklund E. Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs - a Swedish cohort study of risks by time, drug and lymphoma subtype. Rheumatology. 2021, 60:809-19. 10.1093\/rheumatology\/keaa330","journal-title":"Rheumatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac258","article-title":"Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study","volume":"62","author":"Mart\u00edn-L\u00f3pez M","year":"2022","unstructured":"Mart\u00edn-L\u00f3pez M, Galindo M, Pego-Reigosa JM, et al.. Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study. Rheumatology (Oxford). 2022, 62:217-24. 10.1093\/rheumatology\/keac258","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez052","article-title":"Lymphomas complicating primary Sj\u00f6gren's syndrome: from autoimmunity to lymphoma","volume":"60","author":"Nocturne G","year":"2021","unstructured":"Nocturne G, Pontarini E, Bombardieri M, Mariette X. Lymphomas complicating primary Sj\u00f6gren's syndrome: from autoimmunity to lymphoma. Rheumatology. 2021, 60:3513-21. 10.1093\/rheumatology\/kez052","journal-title":"Rheumatology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70327","article-title":"Autoimmune diseases and risk of non-Hodgkin lymphoma: a Mendelian randomisation study","volume":"13","author":"Shi X","year":"2024","unstructured":"Shi X, Wallach JD, Ma X, Rogne T. Autoimmune diseases and risk of non-Hodgkin lymphoma: a Mendelian randomisation study. Cancer Med. 2024, 13:e70327. 10.1002\/cam4.70327","journal-title":"Cancer Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-212376","article-title":"Association of autoimmune disorders and lymphoma: a population-based cohort study","volume":"144","author":"Sukhera A B","year":"2024","unstructured":"Sukhera A B, Vazquez J, Erazo G, et al.. Association of autoimmune disorders and lymphoma: a population-based cohort study. Blood. 2024, 144:6429. 10.1182\/blood-2024-212376","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwn004","article-title":"Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition","volume":"167","author":"Nieters A","year":"2008","unstructured":"Nieters A, Rohrmann S, Becker N, et al.. Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008, 167:1081-9. 10.1093\/aje\/kwn004","journal-title":"Am J Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study","volume":"25","author":"Fallah M","year":"2014","unstructured":"Fallah M, Liu X, Ji J, F\u00f6rsti A, Sundquist K, Hemminki K. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol. 2014, 25:2025-30. 10.1093\/annonc\/mdu365","journal-title":"Ann Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103779","article-title":"Risk relationship between six autoimmune diseases and malignancies: an umbrella review","volume":"24","author":"Yang P","year":"2025","unstructured":"Yang P, Liu Q, Zhang H, Wu M, Zhao J, Shen G, Zhao Y. Risk relationship between six autoimmune diseases and malignancies: an umbrella review. Autoimmun Rev. 2025, 24:103779. 10.1016\/j.autrev.2025.103779","journal-title":"Autoimmun Rev"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.10.028","article-title":"High risk of digestive cancers in patients with celiac disease: a nationwide case-control cohort study","volume":"23","author":"Jannot AS","year":"2025","unstructured":"Jannot AS, Girardeau Y, Chaussade S, Coriat R, Cerf-Bensussan N, Malamut G. High risk of digestive cancers in patients with celiac disease: a nationwide case-control cohort study. Clin Gastroenterol Hepatol. 2025, 23:1258-60.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.8372","article-title":"Diagnosis and management of asthma in adults: a review","volume":"318","author":"McCracken JL","year":"2017","unstructured":"McCracken JL, Veeranki SP, Ameredes BT, Calhoun WJ. Diagnosis and management of asthma in adults: a review. JAMA. 2017, 318:279-90. 10.1001\/jama.2017.8372","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg C","year":"2023","unstructured":"Porsbjerg C, Mel\u00e9n E, Lehtim\u00e4ki L, Shaw D. Asthma. Lancet. 2023, 401:858-73. 10.1016\/S0140-6736(22)02125-0","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.5680","article-title":"Immune-mediated diseases associated with cancer risks","volume":"8","author":"He MM","year":"2022","unstructured":"He MM, Lo CH, Wang K, et al.. Immune-mediated diseases associated with cancer risks. JAMA Oncol. 2022, 8:209-19. 10.1001\/jamaoncol.2021.5680","journal-title":"JAMA Oncol"},{"key":"ref20","unstructured":"National Center for Health Statistics - ICD\u2060-\u206010\u2060-\u2060CM. (2026). Accessed. September 11, 2026: https:\/\/icd10cmtool.cdc.gov\/?fy=FY2026."},{"key":"ref21","unstructured":"Overview of the National (Nationwide) Inpatient Sample (NIS). (2025). Accessed. September 07, 2026: https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17653","article-title":"Adherence to methodological standards in research using the National Inpatient Sample","volume":"318","author":"Khera R","year":"2017","unstructured":"Khera R, Angraal S, Couch T, et al.. Adherence to methodological standards in research using the National Inpatient Sample. JAMA. 2017, 318:2011-8. 10.1001\/jama.2017.17653","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaf244","article-title":"Risk of lymphoma among people with HIV in the United States, 2001-2019","volume":"117","author":"Tao J","year":"2025","unstructured":"Tao J, Luo Q, Haas CB, et al.. Risk of lymphoma among people with HIV in the United States, 2001-2019. J Natl Cancer Inst. 2025, 117:2505-12. 10.1093\/jnci\/djaf244","journal-title":"J Natl Cancer Inst"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00189-X","article-title":"Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis","volume":"25","author":"Jin F","year":"2024","unstructured":"Jin F, Vajdic CM, Poynten IM, McGee-Avila JK, Castle PE, Grulich AE. Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis. Lancet Oncol. 2024, 25:933-44. 10.1016\/S1470-2045(24)00189-X","journal-title":"Lancet Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-4372","article-title":"Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis","volume":"69","author":"Vajdic CM","year":"2009","unstructured":"Vajdic CM, Falster MO, de Sanjose S, et al.. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res. 2009, 69:6482-9. 10.1158\/0008-5472.CAN-08-4372","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01422-6","article-title":"Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study","volume":"16","author":"Inokuchi A","year":"2025","unstructured":"Inokuchi A, Kim H, Sakurai M, et al.. Lymphoma risk in autoimmune diseases with multiple medication use: analysis from the LIFE Study. Blood Cancer J. 2025, 16:11. 10.1038\/s41408-025-01422-6","journal-title":"Blood Cancer J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby KE","year":"2006","unstructured":"Smedby KE, Hjalgrim H, Askling J, et al.. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst. 2006, 98:51-60. 10.1093\/jnci\/djj004","journal-title":"J Natl Cancer Inst"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage JO","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet. 2017, 390:298-310. 10.1016\/S0140-6736(16)32407-2","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies","volume":"125","author":"Anderson LA","year":"2009","unstructured":"Anderson LA, Gadalla S, Morton LM, et al.. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009, 125:398-405. 10.1002\/ijc.24287","journal-title":"Int J Cancer"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-18646-y","article-title":"Correlation between allergy and cancer: a systematic review and meta-analysis","volume":"15","author":"Guo S","year":"2025","unstructured":"Guo S, Fan X, Li W, Bao J, Ma E, Jin H. Correlation between allergy and cancer: a systematic review and meta-analysis. Sci Rep. 2025, 15:34901. 10.1038\/s41598-025-18646-y","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma development in patients with autoimmune and inflammatory disorders - what are the driving forces?","volume":"24","author":"Baecklund E","year":"2014","unstructured":"Baecklund E, Smedby KE, Sutton LA, Askling J, Rosenquist R. Lymphoma development in patients with autoimmune and inflammatory disorders - what are the driving forces?. Semin Cancer Biol. 2014, 24:61-70. 10.1016\/j.semcancer.2013.12.001","journal-title":"Semin Cancer Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419321-associations-between-selected-autoimmune-and-immune-mediated-conditions-and-lymphoma-among-hospitalized-adults-a-national-inpatient-sample-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:14:59Z","timestamp":1789424099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419321-associations-between-selected-autoimmune-and-immune-mediated-conditions-and-lymphoma-among-hospitalized-adults-a-national-inpatient-sample-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.116241","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,14]]}}}